Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

The Annual International Meeting of
Translational Research on Stem Cells, Cell Therapy
and Regenerative Medicine in Industry and Academia
 In collaboration with
 ISCS iati

Dr. Avi Treves

 

IMGP0280sm

Chairman, ISRASTEM 2014
Sheba Cancer Research Center
Center for Stem Cells and Regenerative Medicine

Sheba Medical Center

avi.treves@gmail.com

Main Expertise:
Cell therapy and stem cell technologies;
Cancer immunotherapy;
Translational research and clinical development;
Business development of biotech companies;
Currently the Deputy Director of the Cancer Research Center at the Sheba Medical Center, Israel.
Operating the - Ella Institute for Treatment and Research of Melanoma

Stem Cells Translational Laboratory at the the Sheba Center for Regenerative Medicine

Good tissue culture practice (GTP) facility, development and production of cell based products

Family Cord Blood Bank – Clinical applications

Leading research and development programs for medical applications of adult stem cells from various sources such as peripheral blood, bone marrow, cord blood and adipose tissue. Clinical programs to treat degenerative diseases such as diabetic ulcers and retinal diseases.

Co-investigator in the adoptive immunotherapy program of melanoma, a cell based therapy project in its clinical phase (see publications).

Expert in translational research, regulation and developing cell based technologies, products and their clinical applications. Business development and funding of biotech projects. Adviser and scientific board member for biotech companies. Co-author of more than 90 scientific publications and 10 patents.

Member in the following committees:

  • The Israeli Ministry of Health Committee for Registering of Cellular
  • Based Therapies
  • The Translational Research and Commercialization Committee of the (Chairman) Israel Stem Cells Society
  • The Commercialization Committee of the International Society for Cellular Therapy (ISCT)

Consulting and Scientific Advisory Board member for a number of biopharmaceutical companies including:

  • ImClone Systems Inc., New York, New York (1985-1990)
  • Bio-Rad Laboratories Inc., Brussels, Belgium (1986-1988)
  • Immunovative Technologies, Misgav, Israel (2005 - 2008)
  • Pluristem Life Systems Inc. Hayffa, Israel (2004 - 2011)
  • Taburit Ltd., Tel Aviv, Israel (2004 - present)
  • CryoBanks International, Orlando, Florida (2005 - 2010)
  • SeraCare Inc. USA (2011-2012)
  • Kalia Industries, Israel (2010 – present)
  • Hospira Inc. USA (2010 – 2011)
  • Embryonic Stem Cell Technologies, Israel (2010 – 2012)
  • AssureImmune, Florida. (2012 -)

Contact: avi.treves@gmail.com                    

http://il.linkedin.com/in/avitreves